Results 71 to 80 of about 374 (122)

Nephrogenic Fibrosing Dermopathy: Case report and review [PDF]

, 2006
George, Saira J, Hsu, Sylvia, Lu, Dornechia E George Rebecca   +2 more
core   +1 more source

Nephrogenic Fibrosing Dermopathy With Systemic Involvement [PDF]

, 2003
Mary Seabury Stone, William W. Ting, Kathi C. Madison, Kevin Kurtz   +3 more
core   +1 more source

Clinical Safety of Gadoxetate Disodium: Insights From 20 Years of Use and More Than 12 Million Administrations. [PDF]

Invest Radiol
Endrikat J, Bogosavljev B, Bhatti A, Forgia S, Fuksbrumer MS, Kim S.   +5 more
europepmc   +1 more source

Safety of Gadoterate Meglumine: A Review of 35 Years of Clinical Use and More Than 170 Million Doses. [PDF]

Invest Radiol
Shahid I, Morvan J, Darmon-Kern E, Hebert F, Lancelot E, Bourrinet P.   +5 more
europepmc   +1 more source

Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: COMMENTARY. [PDF]

Kidney360, 2021
Abu-Alfa AK.
europepmc   +1 more source

Nephrogenic Systemic Fibrosis in Patients with Advanced Renal Dysfunction Following Gadolinium-based Contrast Agents. [PDF]

Radiology
Mallepally A, Kidd JM, Grizzard JD, Syed HJ, Chetla N, Carucci LR, Cowper S, Trankle CR.   +7 more
europepmc   +1 more source

Gadolinium deposition in nephrogenic fibrosing dermopathy [PDF]

, 2008
B.H. Thiers
core   +1 more source

Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report. [PDF]

J Korean Med Sci, 2020
Lim YJ, Bang J, Ko Y, Seo HM, Jung WY, Yi JH, Han SW, Yu MY.   +7 more
europepmc   +1 more source

A case of nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis [PDF]

, 2007
Isaac Teitelbaum, Andrew S Weiss, M Scott Lucia   +2 more
core   +1 more source

Nephrogenic fibrosing dermopathy [PDF]

core   +1 more source